While baseline IFNg is higher in the recurrent tumor, the level of TNFa, RANTES (CCL5), IP-10, IL-5, IL-10, MIP1a (CCL3), MIP1b (CCL4), and GM-CSF are all significantly lower in the recurrent tumor. The gene discussed is CCL3; the disease is neoplasm.